Parker JL, Zhang ZY, Buckstein R. Clinical Trial Risk in Non-Hodgkin’s Lymphoma: Endpoint and Target Selection. J Pharm Pharm Sci [Internet]. 2011 Jun. 14 [cited 2025 Nov. 29];14(2):227-35. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/10329